Capital Investment Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$369K Sell
5,759
-447
-7% -$29.4K ﹤0.01% 593
2026
Q1
$442K Sell
6,206
-113
-2% -$8.91K 0.01% 515
2025
Q4
$518K Buy
6,319
+2,568
+68% +$200K 0.01% 477
2025
Q3
$282K Buy
3,751
+3
+0.1% +$224 ﹤0.01% 609
2025
Q2
$278K Buy
3,748
+344
+10% +$23.9K 0.01% 592
2025
Q1
$275K Buy
3,404
+129
+4% +$11.1K 0.01% 570
2024
Q4
$256K Buy
3,275
+111
+4% +$9.44K 0.01% 559
2024
Q3
$297K Buy
3,164
+41
+1% +$3.44K 0.01% 511
2024
Q2
$243K Sell
3,123
-87
-3% -$7.1K 0.01% 537
2024
Q1
$292K Sell
3,210
-127
-4% -$10.6K 0.01% 489
2023
Q4
$258K Buy
+3,337
New +$234K 0.01% 506
2023
Q3
– Sell
-3,486
Closed -$283K – 609
2023
Q2
$283K Sell
3,486
-222
-6% -$17.7K 0.01% 437
2023
Q1
$304K Buy
+3,708
New +$265K 0.01% 442

Other funds holding GEHC

Capital Investment Advisors's GEHC Position: Q2 2026 in Review

Capital Investment Advisors reduced its GE HealthCare (GEHC) stake by 7.2% in Q2 2026, selling an estimated $29.4K and leaving 5,759 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #593.

Capital Investment Advisors first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $518K in Q4 2025. 1,233 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Capital Investment Advisors held 5,759 shares of GE HealthCare worth $369K as of Q2 2026.
  • Capital Investment Advisors sold 447 GE HealthCare shares in Q2 2026, an estimated $29.4K.
  • GE HealthCare made up ﹤0.01% of Capital Investment Advisors's portfolio in Q2 2026, its #593 holding.
  • Capital Investment Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Capital Investment Advisors's GE HealthCare position peaked at $518K in Q4 2025.
  • 1,233 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Capital Investment Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.